Mitchell S. Marder
Mitchell is also the Executive Vice President, Corporate Development and Chief Legal Officer at Cytimmune Science, Inc., a Maryland-based clinical stage nanomedicine company.
As a partner for several national and international law firms, Mitchell represented public and private emerging growth companies and venture capital investment funds in venture capital and other equity financings. He has handled a broad range of corporate and transactional matters, including venture capital financings, public offerings, mergers and acquisitions, general corporate/securities law matters, and intellectual property licensing arrangements.
Bar & Court Admissions
- Massachusetts Bar
- District of Columbia Bar
The George Washington University Law SchoolJD1986The George Washington UniversityBAPhi Beta Kappa1983